Clinical Assessment of Preheated Versus Conventional Bulk Fill Resin Composite
NCT ID: NCT04152460
Last Updated: 2021-02-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
54 participants
INTERVENTIONAL
2020-05-01
2021-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Using Self-adhering Flowable Resin Composite in Repairing Old Defective Resin Composite Restorations Over 18 Months Follow up. (A Randomized Clinical Trial)
NCT06260644
Clinical Evaluation of Self- Adhesive Bulk-fill Resin Composite Versus Conventionally Bonded Bulk-fill Resin Composite in Restoration of Proximal Lesions
NCT04888676
Clinical Evaluation of Different Resin Composite Restorations
NCT05418400
Clinical Evaluation of Bioactive Injectable Resin Composite in Posterior Restorations
NCT05499494
Clinical Performance of Injection-Molding Vs. Incremental Packing of Resin Composite in Cavitated Posterior Teeth
NCT05020093
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Preheating is a method that decreases resin composite viscosity results in better adaptation and wettability of the prepared cavity walls reducing the microleakage.
A new approach based on therm-viscous technology Viscalor bulk (VOCO, Cuxhaven ) a high Viscous composite material at room and body temperature by heating to 68 C converted to flowable consistency.
Preheating composite regarding the lab research have significant clinical advantages as better adaptation reduced leakage and increase of mechanical properties .
Follow up Period will be 1 year , Evaluation will be done at baseline , after 6 months and 12 months .
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Thermo-Viscous preheated bulk fill resin composite
Viscalor Despenser (Preheating dispenser for composite Viscalor Bulk Caps)
Viscalor Bulk (VOCO,Cuxhaven)
Viscalor Despenser (Preheating dispenser for composite Viscalor Bulk Caps)
Conventional Bulk Fill resin Composite
GrandioSo X-tra (Voco,Cuxhaven
Grandioso x-tra
Nanohybrid Bulk Resin Composite
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Viscalor Bulk (VOCO,Cuxhaven)
Viscalor Despenser (Preheating dispenser for composite Viscalor Bulk Caps)
Grandioso x-tra
Nanohybrid Bulk Resin Composite
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with a high level of oral hygiene.
* Patients having at least 12 posterior teeth in occlusion.
* Patients with good likelihood of recall availability.
Tooth Inclusion :
* Permanent premolars and molars.
* Moderate to deep compound class II cavities.
* well formed fully erupted .
* Vital with positive reaction to cold and hot stimulus.
Exclusion Criteria
* Pregnant or lactating females.
* Concomitant participation in another research study.
* Inability to comply with study procedures.
* Heavy Bruxism habits.
* Patients receiving Orthodontic treatment.
* last experience with allergic reactions against any component of used materials .
Tooth exclusion :
* Non vital teeth.
* Secondary carious lesions.
* Teeth with clinical symptoms of pulpitis such as spontaneous pain or sensitivity to pressure.
18 Years
59 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yasmin Atef Ahmed Ibrahim
Assistant Lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Olfat Hasanen
Role: PRINCIPAL_INVESTIGATOR
Cairo University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yasmin
Cairo, Mokattam, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PHD-CU-2019-10-29
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.